Hedge Fund and Insider Trading News: Sculptor Capital Management, Bell Rock Capital Management, Bridgewater Associates, Quintessential Capital Management, Healthcare Realty Trust Inc (HR), Impinj, Inc. (PI), and More

Secretive Hedge Fund Opposes Whitehaven Coal Acquisition of BHP Mines (Clayton County Register)
A London-based hedge fund called Bell Rock Capital Management has emerged as the investor pushing to prevent Whitehaven Coal from acquiring two major mines currently owned by BHP. The Daunia and Blackwater mines, located in Queensland, are expected to receive bids of up to $5 billion. Bell Rock has been aggressively campaigning against the acquisition, calling for increased shareholder returns through dividends instead. Despite the secretive nature of the hedge fund, sources suggest that it holds a significant share in Whitehaven and has been trying to engage with the company’s board for several months.

Wall Street All-Stars Including Weinstein, Ackman Bid for Hedge Fund (The Wall Street Journal)
Drama-plagued Sculptor Capital already agreed to a sale to Rithm Capital. Boaz Weinstein and several other high-profile investors including William Ackman and Marc Lasry have made a rival offer for Sculptor Capital Management SCU 5.67%increase; green up pointing triangle, a hedge-fund firm that already agreed to sell itself to another investment firm.

Is a Hedge Fund-Style Investment Right for You? (Bloomberg)
Former Bridgewater Associates LP executive Bob Elliott’s plan for exchange-traded funds that employ hedge fund strategies has sharpened the debate about whether retail investors should have access to such approaches. The answer broadly is yes, though mostly for investors who understand how these strategies work within a broader portfolio. A second question is whether such sophisticated active management belongs in an ETF format versus an open-end public mutual fund. We’ll need a short dive into history to understand these debates better.

undervalued stocks to buy

Phongphan/Shutterstock.com

US Hedge Fund in War of Words with THG Boss as Matthew Moulding Makes ‘Sour Grapes’ Claim (Business-Live.co.uk)
A war of words has broken out between a US hedge fund and the chief executive of THG, Matthew Moulding. In a LinkedIn post, Mr Moulding renewed his criticism of the London Stock Exchange as well as hedge funds, the media and bank analysts which he accused of being behind negative coverage against listed businesses, including his own.

Opalesque Roundup: Global Hedge Funds Slash Positions in Chinese Companies: Hedge Fund News (Opalesque)
Opalesque Roundup: Global hedge funds slash its position in Chinese companies: hedge fund news. In the week ending August 18th 2023, media reported that global hedge funds are “aggressively” selling Chinese stocks amid heightened concerns over the country’s property sector and a weak batch of economic data, a Goldman Sachs report on Tuesday showed. U.S.-based hedge fund investors including Coatue, D1 Capital and Tiger Global cut their exposure to Chinese companies in the second quarter, as the country’s economic prospects seemed to wobble and geopolitical tension increased. Tiger Global slashed its position in JD.com by roughly 12%, to $719.3 million from $1.1 billion, while also reducing its numbers of shares in Kanzhun. Coatue Management LLC, founded by Philippe Laffont, formerly of Tiger Management, cut its positions in Alibaba, Baidu, JD.com, Kanzhun, KE Holdings, Li Auto and PDD Holdings, regulatory filings showed.

How Hedge Funds are Positioning Themselves for a Soft Landing (Reuters)
Bond, stock and currency market bears with portfolios designed to gain from a recession have been fleeing losing trades as big economies such as the United States prove more resilient than expected. A so-called soft landing, where central banks manage to curb inflation without triggering a recession, has gained traction, prompting some investors to take on more risk. Five hedge funds shared trading ideas for soft-landing scenarios. They cannot reveal trading positions or make recommendations for regulatory reasons.

Billionaire Stan Druckenmiller’s Small-Cap Stock Picks (Insider Monkey)
In this piece, we will take a look at billionaire Stanley Druckenmiller’s small-cap stock picks. If you want to skip our introduction to Mr. Druckenmiller and small-cap stocks in general, then head on over to Billionaire Stan Druckenmiller’s Small-Cap Stock Picks: Top 5 Stocks. Stanley Druckenmiller is one of the richest people in the world. According to Forbes Magazine, his latest net worth estimate sits at $6.2 billion, which is more than enough money to last anyone a lifetime. He is a former hedge fund boss who started out working in the finance industry in the late 1970s and within a couple of years would go on to set up his own hedge fund called Duquesne Capital Management.

Monday 8/21 Insider Buying Report: HR, PGRE (Nasdaq.com)
At Healthcare Realty Trust, a filing with the SEC revealed that on Wednesday, Director John Knox Singleton bought 31,500 shares of HR, for a cost of $17.11 each, for a total investment of $538,965. Bargain hunters can pick up HR at a price even lower than Singleton did, with the stock trading as low as $16.59 at last check today which is 3.0% under Singleton’s purchase price. Healthcare Realty Trust is trading off about 0.8% on the day Monday. This purchase marks the first one filed by Singleton in the past year. And at Paramount Group, there was insider buying on Thursday, by Chairman, CEO and President Albert P. Behler who purchased 70,000 shares at a cost of $4.66 each, for a total investment of $326,490.

Over $15M Bet On Impinj? Check Out These 4 Stocks Insiders Are Buying (Benzinga)
Impinj: The Trade: Impinj, Inc. (PI) Director Daniel Gibson bought a total of 263,740 shares at an average price of $58.26. To acquire these shares, it cost around $15.37 million. Evolus: The Trade: Evolus Inc. (EOLS) Director Vikram Malik acquired a total of 197,965 shares at an average price of $7.41. To acquire these shares, it cost around $1.3 million.

Tuberville’s Stock Trading Raises Questions About Potential Insider Trading (AlReporter.com)
Questions are swirling regarding whether or not Sen. Tommy Tuberville’s, R-Alabama, recent stock trades are an example of insider trading, according to a report by Newsweek. Tuberville caught the eye of financial services website, Quiver Quantitative, who posted on social media last Monday about Tuberville’s trade in a biotech company called Humacyte. Humacyte is a smaller company but has been involved in the war in Ukraine using its technology regarding acellular tissue to help treat those harmed in the war.